Crestline Management’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-35,098
Closed -$504K 124
2017
Q2
$504K Buy
+35,098
New +$504K 0.07% 112